VANI Earnings & Financial Statements
Vivani Medical, Inc.
$1.16
-$0.02(-1.69%)
28
Overall
40
Value
30
Tech
15
Quality
Market Cap
$104.64M
Volume
134.91K
52W Range
$0.92 - $1.92
Target Price
$3.83
VANI earnings and financial statements: Vivani Medical, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
VANI Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cost of revenue | - | - | - | - | $130.0K |
| Operating income | -$27.56M | -$24.68M | -$26.96M | -$21.24M | -$13.32M |
| EBITDA | -$25.92M | -$22.81M | -$24.39M | -$20.86M | -$12.98M |
| Net income | -$26.61M | -$23.49M | -$25.65M | -$13.89M | -$12.77M |
| EPS (diluted) | $-0.43 | $-0.43 | $-0.50 | - | $-0.27 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $39.39M | $41.56M | $45.80M | $51.13M | $5.45M |
| Total liabilities | $23.66M | $23.95M | $25.04M | $6.82M | $2.99M |
| Shareholders’ equity | $15.73M | $17.61M | $20.76M | $44.31M | $2.46M |
| Cash and equivalents | $16.23M | $18.35M | $20.65M | $45.08M | $2.18M |
| Long-term debt | $17.06M | $17.96M | $19.31M | - | $902.0K |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$24.32M | -$20.79M | -$23.70M | -$18.79M | -$10.95M |
| Capital expenditure | -$1.17M | -$556.0K | -$887.0K | -$338.0K | -$572.0K |
| Free cash flow | -$25.49M | -$21.34M | -$24.59M | -$19.13M | -$11.52M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VANI | $1.16 | -1.7% | 134.91K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |